Literature DB >> 2465399

Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.

A J Balaton1, M Nehama-Sibony, C Gotheil, P Callard, E E Baviera.   

Abstract

An antiserum to carcinoembryonic antigen (CEA) and a monoclonal antibody to cytokeratin 19 (CK 19) were studied for their suitability as diagnostic reagents for the differential diagnosis of primary and secondary malignant epithelial tumours of the liver, on paraffin sections. With the antiserum to CEA, positive bile canalicular structures were found in 60 per cent of the hepatocellular carcinomas. All the cholangiocarcinomas and 66.6 per cent of the metastatic carcinomas were positive for CEA, without displaying a canalicular staining pattern. All the hepatocellular carcinomas were negative for CK 19. All the cholangiocellular carcinomas and the metastatic carcinomas were positive for CK 19. This staining profile may prove helpful in difficult diagnostic cases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2465399     DOI: 10.1002/path.1711560405

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

Review 1.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

2.  The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia.

Authors:  Kenneth J Salleng; Frank L Revetta; Natasha G Deane; M Kay Washington
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

3.  Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma.

Authors:  Tzu-Hung Hsiao; Hung-I Harry Chen; Jo-Yang Lu; Pei-Ying Lin; Charles Keller; Sarah Comerford; Gail E Tomlinson; Yidong Chen
Journal:  Transl Cancer Res       Date:  2013-02-01       Impact factor: 1.241

4.  Well-differentiated hepatocellular carcinoma associated with long-term survival. Report of two cases.

Authors:  M Loda; A E Mendoza; C O'Hara; J M Crawford; M Federman; H Goodman
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Markers of bile duct tumors.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Alessandra Rando; Mario Uccello; Francesco Basile; Antonio Biondi; Santo Carnazzo; Innocenza Alessandria; Clorinda Mazzarino
Journal:  World J Gastrointest Oncol       Date:  2011-04-15

6.  Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.

Authors:  F Charlotte; A L'Herminé; N Martin; Y Geleyn; M Nollet; P Gaulard; E S Zafrani
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

7.  Composite liver tumors: a radiologic-pathologic correlation.

Authors:  Megha Nayyar; David K Imagawa; Temel Tirkes; Aram N Demirjian; Roozbeh Houshyar; Kumar Sandrasegaran; Chaitali S Nangia; Tara Seery; P Bhargava; Joon Ii Choi; Chandana Lall
Journal:  Clin Mol Hepatol       Date:  2014-12

8.  A case of combined hepatocellular-cholangiocarcinoma with underlying schistosomiasis.

Authors:  Chang Kyun Hong; Jin Mo Yang; Bong Koo Kang; Jin Dong Kim; Young Chul Kim; U-Im Chang; Jin Young Yoo
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 2.884

9.  Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer.

Authors:  T Uenishi; S Kubo; K Hirohashi; H Tanaka; T Shuto; T Yamamoto; S Nishiguchi
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

Review 10.  The human keratins: biology and pathology.

Authors:  Roland Moll; Markus Divo; Lutz Langbein
Journal:  Histochem Cell Biol       Date:  2008-05-07       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.